Mary Ann Comunale

Title: **Mary Ann Comunale: Pioneering Advances in Hepatocellular Carcinoma Detection**

Introduction

Mary Ann Comunale, an esteemed inventor based in Bangor, PA, has made significant contributions to the field of medical diagnostics, particularly in the early detection of hepatocellular carcinoma. With a remarkable portfolio of seven patents, Comunale’s innovative approaches have the potential to transform patient outcomes in the assessment and management of liver pathologies.

Latest Patents

Among her most noteworthy inventions, Comunale's latest patents include methodologies that enhance the early detection of hepatocellular carcinoma. These patents provide assays and kits designed for diagnosing the condition, as well as stratifying subjects based on their risk levels. Her work addresses the critical need for a highly sensitive predictor of hepatocellular carcinoma, especially in non-symptomatic individuals, utilizing unique combinations of biological factors to achieve unprecedented levels of diagnostic accuracy.

Additionally, Comunale has developed methods for diagnosing liver pathology through the assessment of protein glycosylation. This involves quantitatively detecting lectin binding on proteins in biological fluids and comparing these findings with established reference values to differentiate between healthy and pathological states.

Career Highlights

Mary Ann Comunale has collaborated with prominent institutions such as Drexel University and the Philadelphia Health and Education Corporation. Her work in these organizations has allowed her to push the boundaries of medical diagnostics and innovation.

Collaborations

Throughout her illustrious career, Comunale has partnered with fellow innovators Timothy Michael Block and Anand Mehta. These collaborations have enriched her research and expanded the impact of her inventions, fostering a spirit of teamwork within the scientific community.

Conclusion

Mary Ann Comunale's dedication to improving liver disease detection reflects her commitment to innovation in medical science. With her groundbreaking inventions, she stands as a prominent figure in the quest for better diagnostic tools, driving forward the frontier of healthcare technology. Her work not only highlights the importance of early detection but also exemplifies the power of collaboration among inventors and researchers.